About Us
AMP Pharma is a privately owned Canadian company founded in 1988. As a custom manufacturer1 (CMO) originally, the company now supplies generic pharmaceutical over-the-counter products (Rx or OTC).
In 2006, Louis Pilon acquired the company. With a career in the pharmaceutical industry, first as a sales representative for Bayer in eastern Quebec and the Lower St. Lawrence, Louis rose brilliantly through the ranks of the industry before launching his own business. His dream? Create a Quebec flagship and develop a national market to provide Canadians with a better supply of medicines. His approach aimed at providing a range of innovative products that complemented the existing market controlled by multinationals whose priority was not to supply the Canadian market.
Vacancy Details
Key Roles:
• Providing technical input and compilation of data required for addressing regulatory.
• Review of protocols and reports. PPQP, PPQR, BMR, BPR. Alternate ADL source
related documents DMF, corporative summary reports.
• Assist in deviation, change control and investigation of new and existing formulation.
Co-ordination with cross functional departments for day-to-day activities with CMO and
intra department
• To resolve all the scale-up and production related issues (trouble shooting).
• Successfully transfer the product from approved site to proposed CMO site.
• To propose and fix the batch size i.e. Deno, Scaleup, commercial.
Interested candidates kindly share your profile at praval@jamppharma.com
The app functions as a digital ledger that replaces manual registers for small community groups,…
Now, anyone can make their own Household Mapping , a service that is useful for automatically…
If you want to complete your ration card eKYC through the Mera eKYC App but are experiencing issues like downloading,…
The CSC is a strategic cornerstone of the National e-Governance Plan (NeGP), approved by the…
As a data services company clickworker uses its own trusted platform to set up your data…
To submit your Enumeration Form online (e.g., during the Special Intensive Revision - SIR process),…